High‐throughput metabolomics by 1D NMR

A Vignoli, V Ghini, G Meoni, C Licari… - Angewandte Chemie …, 2019 - Wiley Online Library
Metabolomics deals with the whole ensemble of metabolites (the metabolome). As one of
the‐omic sciences, it relates to biology, physiology, pathology and medicine; but metabolites …

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the …

P Lewczuk, P Riederer, SE O'bryant… - The world journal of …, 2018 - Taylor & Francis
In the 12 years since the publication of the first Consensus Paper of the WFSBP on
biomarkers of neurodegenerative dementias, enormous advancement has taken place in …

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

JA Welsh, DCI Goberdhan, L O'Driscoll… - Journal of …, 2024 - Wiley Online Library
Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of
origin and change the functions and phenotypes of other cells. These features indicate …

Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis

G Disanto, C Barro, P Benkert, Y Naegelin… - Annals of …, 2017 - Wiley Online Library
Objective Neurofilament light chains (NfL) are unique to neuronal cells, are shed to the
cerebrospinal fluid (CSF), and are detectable at low concentrations in peripheral blood …

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

C Barro, P Benkert, G Disanto, C Tsagkas, M Amann… - Brain, 2018 - academic.oup.com
Neuro-axonal injury is a key factor in the development of permanent disability in multiple
sclerosis. Neurofilament light chain in peripheral blood has recently emerged as a biofluid …

[HTML][HTML] Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid

L Jia, Q Qiu, H Zhang, L Chu, Y Du, J Zhang… - Alzheimer's & …, 2019 - Elsevier
Introduction Neuronal-derived exosomal Aβ42, T-tau, and P-T181-tau have been
demonstrated to be biomarkers of Alzheimer's disease (AD). However, no study has …

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

L Novakova, H Zetterberg, P Sundström, M Axelsson… - Neurology, 2017 - AAN Enterprises
Objective: To examine the effects of disease activity, disability, and disease-modifying
therapies (DMTs) on serum neurofilament light (NFL) and the correlation between NFL …

Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis

S Meier, EAJ Willemse, S Schaedelin… - JAMA …, 2023 - jamanetwork.com
Importance There is a lack of validated biomarkers for disability progression independent of
relapse activity (PIRA) in multiple sclerosis (MS). Objective To determine how serum glial …

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and …

J Kuhle, C Barro, U Andreasson, T Derfuss… - Clinical Chemistry and …, 2016 - degruyter.com
Background: Neuronal damage is the morphological substrate of persisting neurological
disability. Neurofilaments (Nf) are specific cytoskeletal proteins of neurons and their …

Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage

L Jia, M Zhu, C Kong, Y Pang, H Zhang… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction Exosomes are an emerging candidate for biomarkers of Alzheimer's disease
(AD). This study investigated whether exosomal synaptic proteins can predict AD at the …